ANTARES PHARMA, INC. 4
4 · ANTARES PHARMA, INC. · Filed Jun 1, 2015
Insider Transaction Report
Form 4
HOBBS EAMONN P
Director
Transactions
- Award
Stock option (right to buy)
2015-05-28+498,310→ 498,310 totalExercise: $2.18Exp: 2025-05-27→ Common Stock (498,310 underlying) - Award
Common Stock
2018-05-28+245,532→ 445,254 total
Footnotes (4)
- [F1]Represents grant of restricted stock units made under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant.
- [F2]The shares reported here represent the total number of securities beneficially owned following the reported transaction, excluding awards of performance stock units previously reported as 182,724 shares of common stock that remain subject to the achievement of a performance goal pursuant to the terms of the award and thus were removed from the total amount of securities beneficially owned.
- [F3]Represents grant of options to purchase shares of common stock, par value of $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan.
- [F4]The options vest in equal quarterly installments over three years from the date of grant.